Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:

Jeito Capital Raises Record US$1.2bn to Bankroll European Biopharma’s Next Generation
Jeito Capital closed its second biopharma fund, Jeito II, at a record $1.2 bn (about €1 bn), making it the largest raise for an independent European biotech‑focused PE firm. The fund will back 15‑20 clinical‑stage companies, allocating roughly $162 m per position across obesity, oncology, neurology and other high‑need areas. Jeito now manages roughly €1.6 bn in assets, tripling its capital base since Jeito I’s $630 m close in 2021, and already boasts exits of up to $3 bn and $1.8 bn. Its investor roster includes sovereign funds, pharma venture arms, insurers and pension funds.
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
Hemispherian AS announced the initiation of a first‑in‑human Phase 1/2a trial of GLIX1 in patients with recurrent glioblastoma and other high‑grade gliomas. GLIX1 is an oral, first‑in‑class small‑molecule TET2 activator that induces tumor‑selective DNA damage and has demonstrated potent preclinical efficacy,...
Forty Years Strong: HMA Marks Four Decades Serving Self-Funded Employers
Healthcare Management Administrators (HMA) marked its 40th anniversary as a leading third‑party administrator for self‑funded employers. Founded in 1986, the firm emphasizes a people‑first culture, unbundled solutions, and deep broker partnerships. HMA reports medical and pharmacy cost trends consistently below...
RoosterBio and MineBio Team up to Expand MSC Solutions Access in China
RoosterBio has signed an exclusive distribution agreement with MineBio Life Sciences to bring its research‑grade and cGMP‑grade mesenchymal stem cell (MSC) and exosome bioprocessing media to China. MineBio has already secured import clearance, allowing rapid fulfillment of orders for both...

DHSC Pledges Plan to Halt Spiraling Cost of Clinical Negligence ‘This Autumn’
The UK Department of Health and Social Care (DHSC) will issue early proposals this autumn to curb the soaring cost of NHS clinical negligence claims, which have jumped from roughly $750 million in 2006‑07 to about $4.5 billion in 2024‑25. A National...

FDA Seeks Input on Digital Health Technologies in Clinical Investigations for Drugs and Biological Products
The FDA has issued a Federal Register notice seeking stakeholder input on the use of digital health technologies (DHTs) in clinical investigations for drugs and biologics. The agency asks for comments on regulatory challenges, guidance needs, and topics for future...

Crunch Time for the WHO
The International Health Reform Project (IHRP) has published the "Right to Health Sovereignty" reports, calling for a fundamental overhaul of the World Health Organization’s structure, financing and accountability. The analysis argues that the COVID‑19 response revealed mission creep, centralized emergency...

Controlling Diabetes without Insulin Injections Thanks to New Implant
MIT researchers unveiled an implantable device that houses insulin‑producing islet cells, shielding them from immune attack and supplying oxygen via an on‑board generator. In mouse studies the encapsulated cells survived at least 90 days, continuously secreting enough insulin to maintain...
Some Common IBS Treatments Are Linked to a Higher Risk of Death, Say Study
A new real‑world analysis of more than 650,000 U.S. adults with irritable bowel syndrome found that long‑term use of certain IBS drugs is linked to higher mortality. Antidepressants were associated with a 35 % increase in death risk, while the antidiarrheals...
Sequencing Method Exposes Hidden Gaps in Immune Signaling by Tracking RNA and Protein Together
University of Miami researchers unveiled CIPHER‑seq, a single‑cell platform that simultaneously profiles RNA and protein within individual immune cells. The method captures cytokine transcripts and their corresponding proteins, revealing the precise timing of immune activation. Compared with conventional workflows, CIPHER‑seq...

Urgent Care Clinics Move To Fill Abortion Care Gaps in Rural Areas
After the Planned Parenthood clinic in Marquette, Michigan shut down, urgent‑care physician Shawn Brown began offering medication abortions at her Marquette Medical Urgent Care. The clinic now provides up to four abortions per week, serving patients from a 500‑mile stretch...
Abortion Clinics Are Closing Nationwide. Could Urgent Care Help Fill the Gap?
After Planned Parenthood shut its Upper Peninsula clinic, Marquette Medical Urgent Care in Michigan began providing medication abortions in July. The urgent‑care, run by Dr. Shawn Brown and staffed by former Planned Parenthood physician Viktoria Koskenoja, now sees about four patients...

How to Spot Signs of Surgical Negligence and Prevent Medical Errors
The Joint Commission reports that wrong‑site surgeries and retained items account for nearly 15% of preventable hospital errors, highlighting a persistent surgical negligence problem. Staffing shortages and rising surgical volumes intensify operating‑room pressure, increasing the likelihood of real‑time mistakes. Early...

Voice Scams: When AI Calls Your Patients, Who’s Responsible?
In 2025, 38% of Americans reported receiving scam calls where fraudsters impersonated their healthcare providers, a surge driven by AI‑generated deepfake voices. Multi‑modal campaigns—combining texts, calls, and emails—have amplified the threat, exemplified by the Kettering Health outage that disrupted patient...

Benefits of All on 4 Dental Implants Compared to Traditional Dentures
All‑on‑4 dental implants, using four strategically placed titanium posts, restore up to 70‑80% of natural bite force and preserve jawbone density, addressing the limitations of traditional dentures that lose up to 25% chewing efficiency within a year. The fixed solution...

First Patient Dosed in CatalYm’s Phase IIb Visugromab Trial
CatalYm announced the first patient has been dosed in its Phase IIb GDFATHER‑HCC‑01 trial, evaluating visugromab as a second‑line therapy for unresectable or metastatic hepatocellular carcinoma. The blinded, randomized study combines visugromab with the PD‑1 inhibitor nivolumab and the tyrosine‑kinase inhibitor...

MOH Releases Details on Updated Salary Guidelines for Community Care Staff in Singapore
Singapore’s Ministry of Health released updated salary guidelines for the community care sector on 8 April 2026, recommending roughly a 7 % increase in total annual compensation for most roles. The new tables detail starting and mid‑point monthly base salaries and median annual...

What Parents Should Know Before Their Child’s First Dental Visit in New Braunfels
The American Dental Association reports that 23% of children ages 2‑5 suffer tooth decay, yet many New Braunfels parents delay their child’s first dental visit until problems appear. Pediatric dentistry recommends scheduling the initial exam by age one, or within...
Halozyme and Vertex Sign Deal for Hypercon Technology
Halozyme Therapeutics’ Hypercon unit has inked a global exclusive licence with Vertex Pharmaceuticals to apply its Hypercon microparticle platform to up to three drug targets. Vertex will pay Halozyme an upfront $15 million plus potential milestones and royalties on any resulting...

STAT+: A Decade Ago, These Drugs Tore Apart the FDA. Today, They Might Be some Patients’ Best Hope
Exon‑skipping therapies for Duchenne muscular dystrophy, once a source of controversy at the FDA, are now delivering unexpected clinical benefits. A recent trial involving 39 patients, including 5‑year‑old Hawken Miller, showed functional improvements that have surprised leading experts. The drugs,...

Is Invisalign Right for Me? Key Considerations and Benefits
Clear aligner therapy, led by Invisalign, now accounts for over 40% of U.S. orthodontic cases, up from 15% a decade ago. The treatment appeals to teens and adults because it’s discreet, removable, and avoids dietary restrictions. Success hinges on patient...
20 Future Swiss HealthTech and MedTech Leaders
Swiss life sciences is shifting from pharmaceutical dominance to a deep‑tech health ecosystem, backed by a surge in venture capital that reached CHF 2.9 bn (≈$3.2 bn) in 2025 – a 23.9% increase. ETH Zurich alone spun out 46 new ventures, leveraging an...
Compassionate Workplaces Are Key to Curing Medical Burnout
Why loving organizations are the secret to ending burnout in medicine [PODCAST] http://dlvr.it/TRwgsy Podcast #HospitalBasedMedicine
Clarity Signs Manufacturing Supply Agreement for Copper-64 With Theragenics
Clarity Pharmaceuticals has signed a large‑scale manufacturing supply agreement with Theragenics to produce copper‑64 (Cu‑64) at Theragenics’ 134,000‑sq‑ft facility near Atlanta. Theragenics can generate about 100 Ci (3.7 TBq) of Cu‑64 per day per cyclotron, enough for roughly 2,000 patient doses. The...

Startup Pitches Brainless Human Clones for Organ Harvesting
Big news about a startup called R3 Bio that plans to create brainless human clones for the sole purpose of harvesting organs when people need them. They are just pitching the idea to investors now, but it is pretty wild (if...

NSAIDs: How Pain Relievers Affect Athletic Performance
What are NSAIDs? https://t.co/GPV7DlHNyD People often take NSAIDs, such as ibuprofen, to manage pain. In this blog, we explore the mechanisms of action of NSAIDs. We also explore how the mechanism may have important implications for athletes. https://t.co/5QGp4HCMTp

Mint Explainer | Anthropic’s $400-Million Biotech Bet: What It Means for India’s Pharma Industry
Anthropic, the creator of the Claude AI model, has acquired stealth biotech startup Coefficient Bio for $400 million in an all‑stock transaction. Coefficient, founded by former Genentech computational drug discovery scientists, brings expertise in AI‑driven molecule design. The purchase underscores a...
GSK's Depemokimab Gains Chinese Approval for Nasal Polyps
#GSK Exdensur (depemokimab) approved in China for treating Chronic Rhinosinusitis with Nasal Polyps, following the ANCHOR trials.

European VC Jeito Gets $1.2B to Help Private Biotechs Control Their 'Destiny'
Jeito Capital, a Paris‑based venture firm, closed its second fund at $1.2 billion (over €1 billion, roughly $1.08 billion). The capital will be deployed to a dozen or so European drug‑development startups seeking to advance pre‑clinical and early‑stage clinical programs. By providing sizable,...

Lithium Reverses ApoE4 Cellular Deficits, Merits AD Trials
https://t.co/r6JzHA1RxM with ApoE4/E4 from a sporadic Alzheimer's disease patient "Given the drug's demonstrated efficacy in reversing ApoE4-driven cellular vulnerabilities, lithium salt warrants further investigation for the treatment of AD." https://t.co/r6JzHA1RxM https://t.co/v2lE0XhN7n
As CGT Manufacturing Scales Up, Automation and Collaboration Become Essential
Cell and gene therapy manufacturing faces a scalability crunch as single batches cost over $500,000 and skilled labor shortages drive high turnover. Companies are turning to robotics, AI, and digital dashboards to automate processes, cut contamination risk, and harness real‑time...

WAFIOS Hosts 2nd Annual Medical Tech Day in Mokena
WAFIOS Machinery Corporation will hold its second Annual Medical Tech Day on June 3, 2026 at its Midwest Technical Center in Mokena, Illinois. The one‑day event gathers medical device manufacturers, technology partners and industry experts to showcase precision manufacturing solutions...
Red Meat Consumption Linked to Lower Risk of Dementia
A long‑term Swedish cohort study of more than 2,100 adults over 15 years found that higher consumption of unprocessed red meat was associated with a slower rate of cognitive decline and roughly half the dementia risk among carriers of the...

Indonesia, UK Shift Research From Lab to Real-World Solutions
Indonesia and the United Kingdom are expanding joint research through the International Science Partnerships Fund, emphasizing the translation of lab discoveries into practical solutions. The partnership, coordinated by the British Council and the UK Department for Science, Innovation and Technology,...

'Doctors Thought My Endometriosis Was IBS'
Endometriosis patients in the UK are facing record‑long diagnosis delays, with new Endometriosis UK data showing an average wait of nine years and four months, up from eight years in 2020. Women like Jade Boden‑de Mel and Emily Knell recount being misdiagnosed with...
Daré's CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
Daré Bioscience, led by CEO Sabrina Martucci Johnson, launched a Regulation A offering to raise $24.3 million, allowing individuals to invest as little as $250. The biotech focuses exclusively on women’s‑health therapeutics, including menopause, fertility, and vaginal‑health products, with its first solo...

Radiology Pushes for $45M to Fund Federal Physician Burnout Program
The American College of Radiology, together with dozens of physician societies, urged Congress to allocate at least $45 million to the Lorna Breen Mental Health Act, the nation’s only federal program aimed at preventing physician burnout and suicide. Since its 2022 launch,...

Siemens Healthineers Partnership Seeks to Boost Supply of Novel PET Imaging Agent
Siemens Healthineers has signed a clinical supply agreement with Australian biotech Radiopharm Theranostics to manufacture and distribute the novel PET imaging agent RAD101 in the United States. The fluorine‑18‑labeled small molecule targets suspected recurrent brain cancer that has metastasized and...
Blackstone and TPG Finalize Hologic Acquisition:
Blackstone and TPG have completed the acquisition of Hologic at $79 per share, including contingent value rights, marking one of the largest med‑tech buyouts of the year. The deal signals a resurgence of mega‑cap private‑equity activity after a period of...

Over 50% of Heart Attacks in Younger Women Aren't From Clogged Arteries
A recent Journal of the American College of Cardiology analysis of patients 65 and younger found that more than half of heart attacks in women are driven by mechanisms other than atherosclerotic plaque, such as oxygen‑supply mismatch, spontaneous artery tears,...
Kent and Medway Mental Health Services Consolidated Under Single NHS Trust
Kent and Medway Mental Health NHS Trust has assumed responsibility for children and young people's mental health services, adult mental health care and eating‑disorder treatment across the region. The integration, effective April 2026, creates the first single‑trust model for these...
WHO Unveils Global Curriculum Guide to Boost Community Health Workers
The World Health Organization today released a Global Curriculum Guide for Community Health Workers and a step‑by‑step integration manual. The resources are designed to help ministries of health improve competency‑based training and embed CHW programs into national health systems, a...
Children’s Hospital Colorado Halts Gender‑Affirming Care for Trans Youth
Children’s Hospital Colorado announced it will cease providing gender‑affirming medical services to transgender patients under 18, a move that has unsettled families and health‑care providers. The decision, made in early 2026, arrives amid a national clash over pediatric transgender care...
Gamified mHealth App Boosts Fitness, Cognition and Mood in College Students, RCT Shows
A randomized controlled trial of 160 Chinese college students found that a gamified mobile health app increased daily steps by 2,114, added 28 minutes of moderate‑to‑vigorous activity per day, and improved executive function and depressive symptoms. The study demonstrates a...
EU Launches PsyPal Project to Test Psychedelic‑Assisted Therapy for Palliative Care Distress
On April 13, 2026, the European Union’s Directorate‑General for Health and Food Safety unveiled the EU‑funded PsyPal project, a research programme that will test psychedelic‑assisted therapy for psychological distress in palliative‑care patients. The initiative signals a policy‑driven push to examine...
Experimental Weight‑loss Drug Retatrutide Sparks TikTok Alarm over Relationship Side‑effects
A TikTok video alleging that experimental obesity drug retatrutide dulls love and libido has gone viral, prompting users to share similar experiences. Researchers and clinicians warn that the drug’s impact on the brain’s reward system could have broader emotional consequences,...
Akeso Reports 7‑month Median PFS for Cadonilimab Combo in PD-(L)1‑resistant NSCLC
Akeso presented updated Phase Ib/II results at ELCC 2026 showing a 7.0‑month median progression‑free survival and a 95.2% disease‑control rate for its cadonilimab‑anlotinib‑docetaxel regimen in patients whose advanced NSCLC progressed after PD-(L)1 therapy. The data suggest a viable second‑line option...

Do Healthcare CEOs Agree on Whether VBC and MA Actually Save Money?
Healthcare CEOs debated whether value‑based care (VBC) and Medicare Advantage (MA) actually cut costs. Some executives, like Arcadia’s Michael Meucci and Risant Health’s Jaewon Ryu, see untapped potential in fraud‑reduction and population‑health management, while others, such as Shawn Gremminger, claim...
Zoll Names Eric Knudsen CEO, Keeps EMT Role Amid Growth Surge
Zoll announced Eric Knudsen as its new chief executive, noting he will retain his volunteer EMT work. The appointment comes as the company’s revenue has risen to $2.4 billion, nearly five‑fold since its 2011 acquisition by Asahi Kasei.
Genetically Engineered Silkworms Spin Spider Silk, a Material Five Times Stronger Than Steel
Researchers have successfully re‑programmed silkworms to spin spider‑silk protein, a fiber five times stronger than steel. The breakthrough, highlighted in National Geographic, could reshape the $6 trillion chemical industry and open high‑strength biomaterial markets in medicine, textiles and sustainable manufacturing.